NOVALAR PHARMACEUTICALS
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
NOVALAR PHARMACEUTICALS
Industry:
Biotechnology Dental Health Care Medical
Founded:
2000-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Total Funding:
97.22 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Ception Therapeutics
Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Current Employees Featured
Founder
Investors List
Domain Associates
Domain Associates investment in Series D - Novalar Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series D - Novalar Pharmaceuticals
SR One
SR One investment in Series D - Novalar Pharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Series D - Novalar Pharmaceuticals
Reference Capital SA
Reference Capital SA investment in Series D - Novalar Pharmaceuticals
Domain Associates
Domain Associates investment in Series D - Novalar Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series D - Novalar Pharmaceuticals
SR One
SR One investment in Series D - Novalar Pharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Series D - Novalar Pharmaceuticals
SR One
SR One investment in Series C - Novalar Pharmaceuticals